# Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity

> **NCT07701005** · — · COMPLETED · sponsor: **Goztepe Prof Dr Suleyman Yalcın City Hospital** · enrollment: 154 (actual)

## Conditions studied

- Steatosis of Liver
- Metabolic Liver Injury
- Obesity
- Overweight
- Insulin Resistance

## Interventions

- **DRUG:** Semaglutide
- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07701005
- **Lead sponsor:** Goztepe Prof Dr Suleyman Yalcın City Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-04-15
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2026-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07701005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07701005, "Non-Invasive Hepatic and Metabolic Index Changes After Incretin Therapy in Overweight/Obesity". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07701005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*